"Ann Intern Med"[journal] 检索结果

1981. Correction: Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease.

来源: Ann Intern Med. 2023年176卷1期144页

1982. Web Exclusive. Annals Video Summary - Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis.

来源: Ann Intern Med. 2023年176卷2期eM223320页

1983. In older adults with recent MI, polypill vs. usual care reduced major adverse CV events at 3 y.

作者: Manoj Kesarwani.
来源: Ann Intern Med. 2023年176卷1期JC3页

Castellano JM, Pocock SJ, Bhatt DL, et al. Polypill strategy in secondary cardiovascular prevention. N Engl J Med. 2022;387:967-77. 36018037.

1984. Statins increase muscle pain or weakness at 1 y, with an absolute excess of 11 events/1000 person-y.

作者: Chirag Bavishi.
来源: Ann Intern Med. 2023年176卷1期JC4页

Cholesterol Treatment Trialists' Collaboration. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. Lancet. 2022;400:832-45. 36049498.

1985. In tobacco smokers with respiratory symptoms, a dual bronchodilator did not reduce symptoms at 12 wk.

作者: Claudia C Dobler.
来源: Ann Intern Med. 2023年176卷1期JC6页

Han MK, Ye W, Wang D, et al. Bronchodilators in tobacco-exposed persons with symptoms and preserved lung function. N Engl J Med. 2022;387:1173-84. 36066078.

1986. Web Exclusive. Annals On Call - Atrial Fibrillation: Control Rate or Rhythm?

作者: Robert M Centor.;Harish Doppalapudi.
来源: Ann Intern Med. 2023年176卷1期eA220001页

1987. Osteoporosis Treatment: Not Easy.

作者: Susan M Ott.
来源: Ann Intern Med. 2023年176卷2期278-279页

1988. In rheumatic heart disease-associated AF, rivaroxaban increased adverse vascular outcomes vs. VKA at 3 y.

作者: Ellis W Lader.
来源: Ann Intern Med. 2023年176卷1期JC2页

Connolly SJ, Karthikeyan G, Ntsekhe M, et al. Rivaroxaban in rheumatic heart disease-associated atrial fibrillation. N Engl J Med. 2022;387:978-88. 36036525.

1989. In type 2 diabetes, liraglutide reduced CV events at 5 y vs. glargine, glimepiride, or sitagliptin.

作者: Krysta Brown.;Anthony A Donato.
来源: Ann Intern Med. 2023年176卷1期JC9页

GRADE Study Research Group; Nathan DM, Lachin JM, Buse JB, et al. Glycemia reduction in type 2 diabetes-microvascular and cardiovascular outcomes. N Engl J Med. 2022;387:1075-88. 36129997.

1990. In type 2 diabetes, glargine and liraglutide each improved glycemic outcomes at 5 y vs. glimepiride or sitagliptin.

作者: Krysta Brown.;Anthony A Donato.
来源: Ann Intern Med. 2023年176卷1期JC8页

GRADE Study Research Group; Nathan DM, Lachin JM, Balasubramanyam A, et al. Glycemia reduction in type 2 diabetes-glycemic outcomes. N Engl J Med. 2022;387:1063-74. 36129996.

1991. In glucocorticoid-dependent polymyalgia rheumatica, tocilizumab improved a composite clinical outcome at 24 wk.

作者: David S Pisetsky.
来源: Ann Intern Med. 2023年176卷1期JC5页

Devauchelle-Pensec V, Carvajal-Alegria G, Dernis E, et al. Effect of tocilizumab on disease activity in patients with active polymyalgia rheumatica receiving glucocorticoid therapy: a randomized clinical trial. JAMA. 2022;328:1053-62. 36125471.

1992. In cancer with dyspnea, high-dose dexamethasone did not improve dyspnea and increased SAEs.

作者: Michael Certo.;Robert Arnold.
来源: Ann Intern Med. 2023年176卷1期JC7页

Hui D, Puac V, Shelal Z, et al. Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial. Lancet Oncol. 2022;23:1321-31. 36087590.

1993. In type 2 diabetes, the BT-001 smartphone app reduced HbA1c more than a control app at 90 d.

作者: Lawrence H Greenblatt.
来源: Ann Intern Med. 2023年176卷1期JC10页

Hsia J, Guthrie NL, Lupinacci P, et al. Randomized, controlled trial of a digital behavioral therapeutic application to improve glycemic control in adults with type 2 diabetes. Diabetes Care. 2022;45:2976-81. 36181554.

1994. In T1DM, open-source automated insulin delivery increased glucose time in target vs. sensor-augmented pumps.

作者: Michael Lockhart.;Sean F Dinneen.
来源: Ann Intern Med. 2023年176卷1期JC11页

Burnside MJ, Lewis DM, Crocket HR, et al. Open-source automated insulin delivery in type 1 diabetes. N Engl J Med. 2022;387:869-81. 36069869.

1995. The War on Reproductive Health Care in the United States.

作者: Carol J Hogue.
来源: Ann Intern Med. 2023年176卷2期276-277页

1996. Short-Term Adverse Outcomes After Mifepristone-Misoprostol Versus Procedural Induced Abortion : A Population-Based Propensity-Weighted Study.

作者: Ning Liu.;Joel G Ray.
来源: Ann Intern Med. 2023年176卷2期145-153页

Prior studies comparing first-trimester pharmaceutical induced abortion (IA) with procedural IA were prone to selection bias, were underpowered to assess serious adverse events (SAEs), and did not account for confounding by indication. Starting in 2017, mifepristone-misoprostol was dispensed at no cost in outpatient pharmacies across Ontario, Canada.

1997. Summary for Patients: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults.

来源: Ann Intern Med. 2023年176卷2期I24页

1998. Summary for Patients: Short-Term Adverse Outcomes After Mifepristone-Misoprostol Versus Procedural Induced Abortion.

来源: Ann Intern Med. 2023年176卷2期I14页

1999. Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians.

作者: Amir Qaseem.;Lauri A Hicks.;Itziar Etxeandia-Ikobaltzeta.;Tatyana Shamliyan.;Thomas G Cooney.; .;J Thomas Cross.;Nick Fitterman.;Jennifer S Lin.;Michael Maroto.;Adam J Obley.;Jeffrey A Tice.;Janice E Tufte.
来源: Ann Intern Med. 2023年176卷2期224-238页

This guideline updates the 2017 American College of Physicians (ACP) recommendations on pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults.

2000. Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.

作者: Chelsea Ayers.;Devan Kansagara.;Brittany Lazur.;Rongwei Fu.;Amy Kwon.;Curtis Harrod.
来源: Ann Intern Med. 2023年176卷2期182-195页

The prevalence of osteoporosis is increasing in the United States.

结果排序

文献格式

出版时间

出版类型

出版语言